福泰制药Vertex Pharmaceuticals Inc. (VRTX) 2015年10-K年度报告「NASDAQ」.pdf

1、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/16/16 for the Period Ending 12/31/15 Address50 NORTHERN AVENUEBOSTON,MA 02210Telephone6173416393CIK0000875320SymbolVRTXSIC Code2834-Pharmaceutical PreparationsIndustryBiotechnology&DrugsSectorHealthcareFiscal Year12/31http:/www.edgar- Cop

2、yright 2016,EDGAR Online,Inc.All Rights Reserved.Distribution and use of this document restricted under EDGAR Online,Inc.Terms of Use.UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-KxANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For t

3、he Fiscal Year Ended December 31,2015oroTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to Commission file number 000-19319_Vertex Pharmaceuticals Incorporated(Exactnameofregistrantasspecifiedinitscharter)Massachusetts04-3039129(S

4、tateorotherjurisdictionofincorporationororganization)(I.R.S.EmployerIdentificationNo.)50 Northern Avenue,Boston,Massachusetts02210(Addressofprincipalexecutiveoffices)(ZipCode)Registrantstelephonenumber,includingareacode(617)341-6100_SecuritiesregisteredpursuanttoSection12(b)oftheExchangeAct:Title of

5、 Each ClassName of Each Exchange on Which RegisteredCommonStock,$0.01ParValuePerShareTheNASDAQGlobalSelectMarketSecuritiesregisteredpursuanttoSection12(g)oftheExchangeAct:None_Indicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct.YesxNooIndicatebycheckmar

6、kiftheregistrantisnotrequiredtofilereportspursuanttoSection13orSection15(d)oftheExchangeAct.YesoNoxIndicatebycheckmarkwhethertheregistrant:(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregistrantwasrequ